Skip to main content
logo
Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
46.48
-0.27 (-0.58%)
At close: Aug 26, 2026, 4:00 PM EDT
46.20
-0.28 (-0.60%)
After-hours: Aug 26, 2026, 7:30 PM EDT

Rigel Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
321.91367.0217.49-25.09-58.57-17.91
Depreciation & Amortization
2.652.422.231.2411.16
Loss (Gain) From Sale of Assets
---0.080.27-0.14-
Loss (Gain) From Sale of Investments
-0.92-1.15-0.71-0.48-0.060.29
Stock-Based Compensation
16.4112.7112.398.8112.399.49
Other Operating Activities
-237.86-285.83--0.683.14
Change in Accounts Receivable
-16.13-10.15-11.079.77-24.850.5
Change in Inventory
-2.52-5.640.761.17-2.38-4.88
Change in Accounts Payable
-3.283.85-3.8-0.373.790.04
Change in Unearned Revenue
-----1.23-0.42
Change in Other Net Operating Assets
-0.87-7.5814.26-1.06-4.3914.47
Operating Cash Flow
79.3975.6631.47-5.74-73.765.88
Operating Cash Flow Growth
20.60%140.40%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
---0.04--0.45-0.63
Sale of Property, Plant & Equipment
--0.10.260.89-
Sale (Purchase) of Intangibles
-70.35--0.36-15--
Investment in Securities
21.29-92.374.4310.4472.33-79.41
Investing Cash Flow
-49.06-92.374.13-4.372.78-80.04

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---19.9519.54-
Long-Term Debt Repaid
--7.5----
Net Debt Issued (Repaid)
-22.75-7.5-19.9519.54-
Issuance of Common Stock
9.388.11.961.052.1262.68
Other Financing Activities
-5.3--13.61-2.63-15.12-
Financing Cash Flow
-22.920.6-11.6418.376.5562.68

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
7.41-16.1123.968.335.57-11.48

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
79.3975.6631.44-5.74-74.215.25
Free Cash Flow Growth
20.67%140.67%----
Free Cash Flow Margin
28.68%25.71%17.53%-4.91%-64.11%3.79%
Free Cash Flow Per Share
4.064.021.78-0.33-4.350.31
Levered Free Cash Flow
-31.7674.6122.99-25.13-39.8310.44
Unlevered Free Cash Flow
-28.1379.1827.93-20.84-37.5213.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
8.26.577.045.852.51.5
Cash Income Tax Paid
1.061.060.330.08--
Change in Working Capital
-22.81-19.510.159.52-29.059.72
SEC Filings: 10-K · 10-Q